Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FTGYU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,891
Award facts
- Contract value 100% obligated
- $32,890.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $32,890.93 for Dupixent 300 mg/2 ml pen injections on September 2, 2025, with completion expected by September 3, 2025. This firm fixed price delivery order represents a non-competitive, unrestricted award and will be performed at the company's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other inflammatory conditions, making this procurement part of DLA's ongoing efforts to supply specialized pharmaceutical products to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.999 billion pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen regularly fulfills delivery orders for brand-name and generic medications, specialty drugs, and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. The company's extensive federal contract portfolio and competitive standing demonstrate its capability to meet urgent and specialized pharmaceutical procurement requirements for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FTGYU?
SPE2DB25FTGYU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FTGYU worth?
The government has obligated $32,891 on SPE2DB25FTGYU.
Is contract SPE2DB25FTGYU an order under another contract?
Yes. SPE2DB25FTGYU is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGYU competed?
The extent of competition for SPE2DB25FTGYU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award